CN Patent

CN115867260B — 用于乳糜泻的吡啶酮衍生物的全身制剂

Assigned to Dr Falk Pharma GmbH · Expires 2024-10-01 · 2y expired

What this patent protects

本发明涉及一种全身制剂，特别是口服制剂，其用于预防和/或治疗乳糜泻，即用于乳糜泻的预防和/或治疗用途。

USPTO Abstract

本发明涉及一种全身制剂，特别是口服制剂，其用于预防和/或治疗乳糜泻，即用于乳糜泻的预防和/或治疗用途。

Drugs covered by this patent

vonoprazan-fumarate (VONOPRAZAN FUMARATE)

Patent Metadata

Patent number: CN115867260B
Jurisdiction: CN
Classification: —
Expires: 2024-10-01
Drug substance claim: No
Drug product claim: No
Assignee: Dr Falk Pharma GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.